Murat Akand

14PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesTraditional Chinese medicine and treatmentsOccupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 15, 2026
Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression.

|Mar 24, 2026
Response to the Li et al. comment on 'Overall survival benefit after prophylactic urethrectomy: true oncological effect or unadjusted selection bias?'

Murat Akand, Hendrik Van Poppel

|Dec 23, 2025
Prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: does it really have an effect on oncological outcomes?

Jonas Mennes, Murat Akand, Rodrigue Benijts

|Dec 05, 2025
Comment on: "To stop or not to stop. Endoscopic enucleation of the prostate in patients on blood thinners: outcomes, a real-life prospective multicenter study of 932 cases".

N Zafer Tokatli, Murat Akand

|Nov 10, 2025
Comment on: "Intravesical administration of highly concentrated hyaluronic acid and chondroitin sulphate as add‑on therapy for chemical cystitis induced by Bacillus Calmette-Guérin (BCG) immunotherapy".

Murat Akand, Ozcan Kilic, Wojciech Krajewski

|Nov 09, 2024
Cohort Profile: VZNKUL-NMIBC Quality Indicators Program: A Flemish Prospective Cohort to Evaluate the Quality Indicators in the Treatment of Non-Muscle-Invasive Bladder Cancer.

Murat Akand, Ralf Veys, Dieter Ost

Pageof 3

Frequent Collaborators

4 joint publications

Steven Joniau

3 joint publications

Özcan Kılıç

2 joint publications

İsmail Harmankaya

2 joint publications

Maarten Albersen